RADORUS Trademark

Trademark Overview


On Tuesday, September 15, 2020, a trademark application was filed for RADORUS with the United States Patent and Trademark Office. The USPTO has given the RADORUS trademark a serial number of 79298109. The federal status of this trademark filing is REGISTERED as of Tuesday, July 27, 2021. This trademark is owned by Mitsubishi Tanabe Pharma Corporation. The RADORUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
radorus

General Information


Serial Number79298109
Word MarkRADORUS
Filing DateTuesday, September 15, 2020
Status700 - REGISTERED
Status DateTuesday, July 27, 2021
Registration Number6430674
Registration DateTuesday, July 27, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 11, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMitsubishi Tanabe Pharma Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameMitsubishi Tanabe Pharma Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameMitsubishi Tanabe Pharma Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Sunday, December 26, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, December 7, 2021FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 7, 2021FINAL DISPOSITION PROCESSED
Wednesday, October 27, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, May 11, 2021NOTIFICATION PROCESSED BY IB
Tuesday, May 11, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 21, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 21, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 1, 2021REFUSAL PROCESSED BY IB
Sunday, February 7, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, February 7, 2021REFUSAL PROCESSED BY MPU
Friday, January 29, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, January 28, 2021NON-FINAL ACTION WRITTEN
Thursday, January 28, 2021ASSIGNED TO EXAMINER
Tuesday, November 24, 2020APPLICATION FILING RECEIPT MAILED
Friday, November 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, November 19, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB